Centessa shareholders approve Lilly acquisition; court sanction hearing June 22

Centessa Pharmaceuticals plc

Shareholders voted 126,653,456 for vs 23,007 against (99.98% of votes cast) to approve the scheme of arrangement.
All seven shareholders of record voted in favor; no shareholder voted against.
Court sanction hearing scheduled for June 22, 2026 at Royal Courts of Justice, London.
Acquisition by Eli Lilly via court-sanctioned scheme expected to close following court approval.

Featured in Daily 8-K Digest

Selected #3 for 2026-06-12. Read digest

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.